Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Telfast 180mg¹°


Contraindicated

Not recommended
Telfast 180mg¹° :
Type Medicine Withdrawn
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Manufacturer Benta SAL
Manufacturing Type Under license from Sanofi Aventis France
Origin Lebanon
ATC R06AX26

Your comment will appear shortly after approval

Telfast 180mg¹° :

Revision Date : 23/08/2016


Effect Frequency
Anaphylactic reactions Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Cephalea Common
Chest tightness Not known
Diarrhoea (Diarrhea) Not known
Dizziness Common
Dreaming excessive Not known
Dry mouth (Xerostomia) Not known
Dyspnoea (dyspnea) Not known
Fatigue Uncommon
Flushing Not known
Hypersensitivity reactions Not known
Insomnia Not known
Nausea Common
Nervousness Not known
Nightmares Not known
Palpitations Not known
Paroniria Not known
Pruritus Not known
Skin rash Not known
Sleep disorder (Sleep disturbance) Not known
Somnolence Common
Tachycardia Not known
Urticaria Not known

Different Units By MoH Code

Revision Date : 01/09/2012

Telfast 180mg¹° Telfast 180mg¹° Telfast 180mg¹° Telfast 180mg¹° Telfast 180mg¹° Telfast 180mg¹°

Telfast 180mg¹°  MoH 5443 :
Form Tablet, Film-Coated
Packaging Blisters (Al/PVC/PVDC)
Package Size Box of 15
Strength 180mg
Storage Condition <25°C Away from moisture
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 221946/09
Submission date 01/01/2009
Registration Year 2009
Withdrawn Date 2016


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info